Clinuvel Pharmaceuticals buy Savour
Start price
20.03.19
/
50%
€16.90
Target price
07.12.19
-
Performance (%)
-1.89%
End price
07.12.19
€16.58
Summary
This prediction ended on 07.12.19 with a price of €16.58. With a performance of -1.89%, the BUY prediction by Savour finished with a loss. A total of €0.015 was paid as dividends for this prediction. Savour has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Clinuvel Pharmaceuticals | -2.181% | -2.181% | -1.780% | -47.243% |
| iShares Core DAX® | 0.869% | 3.389% | 22.351% | 71.506% |
| iShares Nasdaq 100 | -0.852% | -2.157% | 5.543% | 107.710% |
| iShares Nikkei 225® | 0.436% | 1.060% | 13.273% | 46.809% |
| iShares S&P 500 | -0.122% | -0.270% | 3.350% | 65.323% |
Comments by Savour for this prediction
In the thread Clinuvel Pharmaceuticals diskutieren
Savour stimmt der Buy-Einschätzung von Maxi-Scalibusa zu
Savour stimmt am 20.03.2019 der Buy-Einschätzung von Maxi-Scalibusa mit dem Kursziel 19,5€ zu.
Überschrift: Highflyer
Stopped prediction by Savour for Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€17.85
22.12.19
22.12.19
-
11.07.20
11.07.20
-23.08%
11.07.20
11.07.20
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€16.60
07.12.19
07.12.19
-
22.12.19
22.12.19
7.53%
22.12.19
22.12.19